standing,purpose for any bulk drug,drug policy confers discretion,recovery,reasonable,pharmaceutical,tenuous,government of india,ingredient,meticulous,at least  bulk drug producers,one or more norm,ranbaxy laboratories,bulk drug manufacturer in the country,reasonable limit,vulnerable,spirit,dependent,notified price prevalent during the relevant period,at least  bulk drug manufacturer,affidavits,starting result,determine the extent,indian,likely spurt,various factor,petitioner in wpno,annual turnover needs,furnished the best indicia,own guidelines,these reasons,minimum annual turnover requirement,drug in the schedule,foreign countries,same form,be no fixation,choosing some drug,be infraction,extent,important bulk drug,broadest meaning to the expression,special niche,test,only seven known formulator,meeting the points,purview,of the overcharged,in term of the policy,be the notices,matter,axiomatic that the content of a policy documents,purview of dpco,org datum,goods,domestic sale turnover,estimate the sale value,countries,legislative power,drug cloxacillin,calculating market share,bulk drug procedures,lays down specific criterion,when the plea,above criteria,doorstep of the respondents,attention of the high court,pending fresh determination,names,modifications in drug policy,regard to other aspects,due regard to the observations,factum,consideration,claimed the benefit,highest,arguments,statutes,bald plea,relevant data,based formulations,been the connotation,questions,relevant material,ceiling level beyond which increase,b,rational assessment of the factors,deposit the overcharged amounts,minimum annual turnover of rs,desirable,burden,cloxacillin,leaving other,nd,experts,official,distinction,single manufacturer,subjective,addition,less,due allowance,total indigenous production in the country,prices of such medicines rise,group,term  formulator,that order,picture,sale of the bulk drugs,clauses in para,when the actual figures,theme of the arguments,import value,file,twin conditions of a minimum,withstand the test,exclusion,distribution,seeks exclusion,averment in paragraph,number of bulk drug producers,org data,drug manufacturer in the country,service,wrong,methods of calculation,simple,para,set norms,entire schedule,second schedule to the drugs,framing the legislation,first schedule,clause in para,sector,turnover as nothing,complaint of violation,high court,allowance to various factors,th,upto,give data,relation to each drug,views,more bulk drug,approach,bulk drug  glipizide,then prevailing market price,was a single formulator,justifiable,written submissions,summarize the conclusion,producers of the particular bulk drug,issue of export sales,legal sense,received attention,unreasonable and ultra vires,disease,trends of prices,erroneous assumption,grounds on which subordinate legislation,as many as  bulk drug procedure,only bald denial,to the institutions,produced the bulk drug,is no good reason,mainly center,intrinsic,not the case,various levels throughout the deliberations,import value of the drug,only a halfhearted attempt,dpco on the basis,be the manufacturer,give liberty,such formulations,st,retail sale data pertain,liberty,clear that the high turnover of a drug,same para,high court s judgment,vindicates the objective,annual,formulations of a bulk drug,product,bulk drug at a price,bulk drug manufacturers in the country,plea,that calculation,cipla ltd,basi,dt,two bulk drugs,dual role of policy - maker,pricing mechanism,writ petition record,subjective approach,other fiscal enactment,two views,objective of primary legislation,conformity with that policy,price control,turnover for the purpose,implementation of the drug policy,government in exercise,annual turnover of the bulk drug,vide extb in wpno,bulk drug doxycycline in a concentration,exercise,diagnosi,understood in trade,excluded from the dpco,drug under dpco,all these reasons,findings,advanced,contentiou,bulk drug on the basis,number of single ingredient formulators,available for the year,including drug,nobodys case,from org datum,the dpco,sit in judgment,question whether export sales,court s view,modality,comparable,best indicia,government as the delegate,other provision,mefenamic acid,mg,include export,nothing,drugs from dpco,is nobody,bulk drug sale,give datum,control,mere,annual domestic turnover of the drug,by the mrp,cosmetics act,government s decision,reliable datum,assumption that insulin,determinative of turnover,central government,affidavits on record,lacs turnover,which increase,furnish some basi,best indicia of domestic sale turnover,substance,sole manufacturers,role,concepts,basi of the single ingredient formulation,in terms,value thereof,pursuant,account of turn,imprint,leaving others,period,erroneou,essential commodities,therein,bombay high court,due regard,p,bombay,correctness of the writ petitioners,fresh,writ petition,ingredient formulator,situation,collin,discussion on the controversies,turnover of the specified drug,known formulator,afresh,local,was an obvious error,deviation,financial,categorization,concerned bulk drug,said word,retail sale data pertain to formulations,reclaim price control,pharmaceutical pricing authority,two aspects,multi-ingredient formulator,concerned statutory authority,standing committee,step,includes formulation,mrp,that article,producer,sale data pertain to formulations,drug amikacin sulphate,said order,absence of availability,associate,constitution by the manufacturers  importers,ground of arbitrariness,further case,monopoly situation in cases,term of gross revenue,act,slp paper book,facts,when the burden,fresh determination by the high court,drugs under dpco,delegate,drug policy,entering the retail market,documents,further case of the writ petitioner,same certificate,import statistic,scheduled drug,prescribed norm,affidavit on record,criteriaguideline,go - bye to the policy guidelines,lac,adequate competition,combination formulation,promulgating the dpco,upheld such plea,batch of writ petitions,compliance,norfloxacin,value,points,aberrations,particular,modification,to the government,rejected the representation,that indigenous production,giving broadest meaning,fixation of price,essential commodities act,why the union,classifying the drug,use,construction,actual,said criteria,price scenario from different points,hence,union,bulk drug stand,denial in the counter affidavit,potential,predominance,certain factual aspect,indian express newspapers,effective rebuttal of the averments,mitigation,statistic,actual sales within the country,accepted the claim,limited,busines during certain period,word,understand the true import,organizations,violative,give a go-bye,criteria,immediate provocation,mean domestic sales figure,supplies,manufacturers  importers,derivative,detail,burden lies,normal trade channel,plea of violation,account,more than  market share,containing the bulk drug doxycycline,sale turnover,forces,pre-fixed guideline,rational assessment,promoting the rational use,transparent  objective and verifiable manner,aggregate,bulk drug manufacturers association,credibility of the version,export sale figure,more than  lacs,specific,different method,values of bulk drugs,excess,international market as a dependable exporter,relevant facts,drug for the purpose,avowed,exactitude,org survey,position,second,rd,consumption within the domestic market,turnover for the relevant year,learned solicitor general,writ petitioners,open,list of drugs,case,approach of the high court,consideration as regard,subject of inclusion  exclusion,is sufficient market competition,is a prohibition,regarding the turnover,government,two aspect,modification in drug policy,total business,taking the export sale figures,mefenamic,of article,pharma market,self - evolved criteria,only rs,than five bulk drug producers,market as a dependable exporter,indicia of the total business,value of bulk drugs,batch,market share in excess,sale datum of the formulations,nppa sent,org-marg cover,criterion,five bulk drug producers,only one manufacturer,relevant period,institutional sale,thing,price of these drugs,various crucial aspect,all the drug,either deviation,examine the facts,reconsideration,terms,took the date,sale datum,verification,irrelevant,payable,law - making authority,purpose,taking the export sale figure,disclosure,drugs for price control,primary legislation,figures,at least five producer,subject the petitioner,supplies of the specified bulk drug,only question,drugs policy,prevention of disease,claims,lays down specific criteria,production value,angles,priced pursuant,of the over,apply the criteria,trend of prices,eligible,external use in the diagnosis,committee,interest of transparency,kept outside price control,doing violence,specified drug,other drug,much of legalism,sufficient,go hay-wire,institutions,word  turnover,broad,said bulk drug,drug with the minimum use,market sales,relevant year,such plea,estimates,has multi-ingredients,notices,piece,estimated basi,disclosure of material facts,claim exclusion,doorsteps of the respondents,r,full and clear picture,relevant criterion,other producer,sales turnover,importers,stand of the appellant,bulk drug during the relevant period,turnover of doxycycline,in the sense,such matters,section,basi of a bald plea,crores,resultant legislation,human beings,called principle,element of arbitrariness,actual datum,short,retail pharma market in india contributes,account of predominance,pleasure,agreement with the high court,relevant since the need,ext,task,objective and verifiable manner,entire,declared objective,sale,drug manufacturers in the country,writ petitions,conformity,watch,order,inclusion,including the drugs,drug ingredient formulation,unreasonable,regard to the observations,india,drugs of popular use,director,amikacin,than  lacs,crucial issues,from the affidavit on record,such an approach,imports of bulk drug,pharmacopoeia,ground of slp,and earnest attempt,power,stock,alia,absence,listing of drugs,drug cyproflaxacin,calculation of turnover,bringing the drugs,opening clause,union of india,bulk drug in the first schedule,meaning to the expression,light of the apprehensions,certain drug,objectives of primary legislation,es venkataramiah,price scenario,producer of the particular bulk drug,nppa in response,applying the above criteria,supply of the specified bulk drug,least ten formulator,bulk drugs into account,annual turnover of the bulk drug doxycycline,anti,single ingredient formulations,prevention,sells single ingredient formulation,various crucial aspects,reference to the data,entire stock in trade,plenary,retail price,procedure,retail sale datum of the formulations,retail sale data,usage in foreign countries,officials of the department,regard to the terms,knowledge,action,levels throughout the deliberation,popular,affidavit of union,counter affidavit,why export sale,foundation,usage,contents of a policy documents,export,such sales,entire stock,market share of single drug ingredient formulation,chemicals,difference between the value,within the period,only r,regarding mefenamic acid,computing the annual turnover needs,sought the benefit,drugs in the first schedule,vast difference between the value,certificate,such discretion for relevant reasons,as many as  formulation,norm,hostile discrimination,drug and another anti - diabetic drug,question,experimental,denial in the affidavit,doorstep,permissible,tenuou,answered that question,obvious reference,rational,quoted supra,esters,respondents that the bulk drugs,brand name of glynase,averments in paragraph,be negligible ie,contention of the petitioner,never the case,competent legislature,arbitrariness,clarity,salbutamol,lacs during the relevant period,more than  lac,supply,basis of the single ingredient formulation,one or two drugs,country in relation,five known manufacturer,finding,medicines rise,classification of certain drugs,general,deduce the consumption,given period,judge,discussion,complaint,animals,retail trade,vire,admittedly  bulk drug procedure,arguments of the learned counsel,is the only drug,dual,high court on guard,the drugs,institution,multi,expanse of the expression,sales of the bulk drugs,internal or external use,basis that the government,lower turnover,whatever,judgment under appeal,terms of production,purview of price control,ingredients,gross revenue,formulators in respect,pieces of medicines,determines the annual turnover,grey area,further respectful submission,fallout of the breach,writ,court on guard,turnover,applicability of criteria,other provisions,pharma,sweet,absence of such disclosure,definition,single ingredient of the bulk drug,domestic consumption,reliable,usv,purposive manner,controversy,comprehensive data of sales,learned solicitor general at the time,schedule on the basis,manufacturers of the bulk drug,methods without reference,year on the basis,meticulous conformance,pages,purported implementation of the drug policy,policy-maker,policy paper,government s resolve,such medicine,expedite hearing,retail,india that any different criteria,various formulations,bulk drug,petitioners  version,reliable data,ground,transparency,relevant criteria in the drug policy,such to the institutions,vagueness,document,name,relevant fact,factual aspects,department,exercise of the review,represents the value,at least  bulk drug producer,increasing supply,understanding,two drugs,export potential of the drug,bald,weeks,of the arguments,from the org datum,seek any assistance,accepted meaning of the expression,ranbaxy ltd,various level,appropriate measures,rational use,allowance,clear from the reply,arbitrarines,for the purpose,is any doubt,other standard,able,furnish the basis,whole issue,firm,dual role,interests of consumers,price control criteria,sale data pertains,formulations,suitable for policy issues,turnover of rs,relevant aspects,grounds,landed cost of imports,is no quarrel,lac during the relevant period,claimed exclusion,earlier dpco,the drug,nature,prohibition,other drug amikacin sulphate,scheduled,said criterion,rs,simple reason,statutory authorities,e,be no presumption,market share in the retail trade,letter,statutory provision,minimum annual turnover,important,associate research director of org,regard to the turnover figures,information,value of stock,import into the country,import,discrimination,harp,using the word turnover,iv,ascertaining the annual turnover,regarding glipizide,updating the list,be no doubt,only three manufacturer,entire production,firm factual foundation,accepted meaning,available under paragraph,reference to consumption,increase,such discretion,inclusionexclusion,consumer,central theme of the arguments,plea of the writ petition,corollary to this stand,none,pave the way,put the high court,brand name of cifran,concerning the criteria,retail sale data pertains to formulations,org compilation,ambit of turnover,human,org figures for the year,same degree of immunity,such disclosure,stereo-isomers,provision,rejoinder affidavit in relation,is vast variation,intricacy of price fixation,exclusion from the purview,go,use of drugs,figures for the year,pre,inevitable fallout of the breach,gros,tune,stock in trade,nppa sent to the bulk drug manufacturers,is controversy,sole guide,wire,bulk drug into account,available at a fair price,deliberation,org data relate to sales,no doubt,drug under price control,the relevant material,express newspapers,domestic turnover of the drug,monopoly situation,companies,only three manufacturers,org-marg covers,such case,only drug,will,sales values,for policy issue,fair,discretion,assertion,certain bulk drugs,unsold stock,ie,considered the representation,legislation,provisions,is the turnover,issue of  annual turnover,filing the writ petition,attempt,work,making such inquiry,more norms,two bulk drug,financial year,manufacture of formulations,combination products of cloxacillin,value of the goods,figure by an expert group,set pattern,nature of the claim,reaching the conclusion,piece of subordinate legislation,ingredient in any formulation,drug at a price,reliable and comprehensive data,money,further respectful submission of the petitioner,objectivity,treating the turnover,combination product,sale of formulations,rd criterion,charter for the resultant legislation,round the quantum,rebuttal of the averments,bulk drug producer,view that single ingredient formulators,statutory,aspect,deviate therefrom,drugs for the purpose,not the sole guide,equate turnover,transparent criterion,particular bulk drug stands,turnover needs,verifiable,diagnosis,viz,stand that the turnover,popular use,reach,actual sales,retail sale datum,derivatives,representation,reasoned,price control in case,said two drugs,learned counsel,retail store audit,self - evolved criterion,obvious reference to consumption,govt,ultra vire,modifications,time,content,sale to the extent,express,ranbaxy,provocation,such as hospitals,conclusion of the high court,delegated,objectives of the policy,court s judgment,week,sales tax,vast,apprehensions,trade sale datum,also the contention,drug in question,seven bulk drug,value of weighted average,values,best,expres,medicine,expanse,correctnes of the writ petitioners,at the doorsteps of the respondents,case of the writ petitioners,eligible for exclusion in the light,view,scope,unsold,further probe,same on the ground,six bulk drug producers,period of time,sale value of formulations,disputing the assertion,inevitable,correctnes,overcharged amount in relation,products,such inquiry,is the case,glynase,connotation of the word,therefore the drug,mean of imports,earnest attempt,rule,turnover of the bulk drug,three relevant criteria,relevant time,solicitor,sale data of the formulations,relevant information,since the need,producing doxycycline,argument of the learned solicitor,org,petitioner,aid,case of cyproflaxacin,market competition,indigenous,conclusions of the high court,result,amount,criteria in clause,such as wastage,consumers,against the spirit of the policy,ordinary sense,center,annual turnover for the year,consumers through normal trade channels,direct sales to institutions,total,misapprehension,to the provision,be an element,formulator,mere vagueness,opening,all the relevant material,is the contention,more norm,stand of the appellants,said turnover,examine the fact,form,concerned drug,scheduled bulk drugs,court,pharmaceutical aid,observation,market share of the formulation,were the sole manufacturer,therefore,degree,regard to the criteria,formulation,question whether export sale,scheduled bulk drug,mischief of clause,relevant reasons,expert group in case,merit,immunity,maximum retail price,medicines,variou,close watch,is the annual turnover,expert group on the basis,manufacturers  importer,stand of the government,biological,single formulator,manner,first time,mainly centers,demanding overcharged amount,glibelclamide,question of applicability,debilitate the set norms,guidelines,alleged infraction,domestic consumption of the bulk drug,cipla,sales of formulations,hearing,institutional sale to the extent,discernible from the affidavits on record,reaching a conclusion,due allowance to various factors,costs,levels throughout the deliberations,frank disclosure of material facts,combination with other drugs,bring these important bulk drug,ending march,paper book,drugs manufacturers association,five bulk drug producer,economic considerations,market share in retail trade,trend,much more than  lac,plea of discrimination,depends,preferable,same in the manufacture of formulations,standards,sales to institutions,when the selection,averment,as hospital,least,that year,broad manner,solicitor general,in terms of the policy,data of sales,certain period,basi of clause,org data relates,sum total of production,harp on org data,was the measure,accepted the plea,apparent misapprehension,requirements of objectivity justifiable,overcharged amounts in relation,nobody s case,domestic turnover,established criterion,dictionary,stated--,retail market sale,relevant aspect,regarding sales,other producer of bulk drug,has nothing,comparable in terms,overcharged amounts,above drug,unsold stocks,impracticable,landed cost of total imports,price fixation,comprehensive data,accuracy,applicable,respondent,version of writ petitioners,doubt that the meaning,obviou,different purpose,petrochemicals,that the production,denial,writ petition at pages,drugs in question,ultimate,drug policy with regard,ten formulator,view that the approach,theme,only the name,that monopoly situation,furnish the basi,keep a close watch,good reason,impracticable of compliance,rules,government s stand,institutional sales,scrutiny,of market share,is sufficient market competition viz,export performance of the industry,store audit,particular bulk drug stand,fiscal,one drug,retail pharma market,slp paper books,admittedly  bulk drug procedures,more number,choosing some drugs,annual turnover for the purpose,part,validity,accordance with the objectives,ceiling,much more than  lacs,first time in the rejoinder affidavit,domestic production,mere vaguenes,was effective rebuttal,adequate,appeals by special leave,scope for ambiguity,central theme,lay firm factual foundation,drug qualifies,counter affidavit that the retail trade sale datum,account in the context,resultant,exces,taken the stand,treatment,oversimplified the whole issue,bulk drug procedure,quantum of bulk drug,varying methods,examined the intrinsic worth,india contributes,body of experts,paragraph in the drug policy ie,at the doorstep of the respondents,government organizations,mean sale,policy documents,for the year,reference,bulk drugs manufacturers association,drug for price control,reddi,drug into account,aberration,fallout,total production in the country,terms of gross revenue,retail market sales,average,drug salbutamol,cosmetic,domestic,expert group,decade,even prima facie acceptance,legislation on the ground,godown,sale to institutions,assessment,country,hospitals,was r,import of bulk drug,survey of march,varying method,theophylline,factual particular,respondents,comprehensive,amount subject to the payment,formulator in respect,purported implementation,combination products,correctness,particular of sales,drug under the price control,expression  formulator,regulate the equitable distribution,ordinarily accepted meaning,filing the writ petitions,lack of clarity,conformance,hostile,more point,including drugs,various angles,discrimination on that account,imprint of arbitrariness,known manufacturer of bulk drug,called the national pharmaceutical pricing authority,indicated supra,ranbaxy laboratory,officials,support,sale data pertain,sales of bulk drug,crore,dpco,from the org data,counter,purpose of clause,total domestic consumption of the bulk drug,therein that the intent,org publication,delegated legislative power,known manufacturers,accordingly we direct stay,methodology,known formulators,announces a rational policy,objective of the policy,time of argument,brand name,movement of prices,ingredient formulators,is a manufacture,issues,case of the writ petitioner,very objective,exclusion criteria,wide latitude,notify the specified drug,exports,frank,entirety of production,express newspapers v union,norms,six bulk drug producer,distorted,known formulator of the bulk drug,england,total import into the country,be the data,where the delegate,number,representation of the bulk drug manufacturers,callousnes,annexure,available,from the reply,such medicines rise,appellant,firm factual foundation in support,wrath,and ultra vire,plant,india that any different criterion,turnover figure,different methods of calculation,inevitable fallout,concepts of  turnover,including the drug,turnover of bulk drug,prescribed norm in drug policy,mean domestic sales figures,sufficient market competition,original record of high court,particular reason,seven formulator,upholding such plea,sole manufacturer,formulations of scheduled drugs,highest market share,substance of the arguments,such selection,is a transparent,purposes,deviating therefrom,intricacy,stand that the bulk drug turnover,quantity of bulk drugs,manufacturers of formulations,variation between the quantity,only the names,modality of fixation,disclose the number,known formulators of the bulk drug,narrow connotation,total domestic consumption,vide extb,notice,stand point,exclusion of some drugs,none of the formulators,rational basi,bulk drugs,isomer,factual particulars,vast variation,role of policy - maker,total indigenous production,matter of selection,independent,is no dispute,indigenou,formulation of scheduled drugs,aspects,reflects a reasonable view point,be the notice,above criterion,exporter,case of the government,are the questions,disregarding the very fact,domestic market,obvious,endeavour,manufacture of the bulk drug  glipizide,formulators,stipulated level,wpno,paper,prices of these medicines rise,analysis,case that clause,of the argument,alleged discrimination,th january,to the provisions,adopt transparent criteria,includes export sales,local tax,selection,competent,drug policy ie,regarding exclusion,such exclusion,case of the union,other reliable and comprehensive datum,interests,as wastage,summarize the conclusions,is a single formulator,facie,lakhs,having a market share,determination,business during certain period,channel,connotation,org data relates to sales,central,remedy by way,be a ground,year,estimate,high turnover,drug,obvious error in the high court,expert,particulars,classifying the drugs,mathematical accuracy,plea of the respondents,deserves notice,amongst,newspapers,material,monitor the trend,competition,cipla ltd inter alia,datum of sales,vide annexure at page,term of the policy,earlier,parliament,direct sales,where a monopoly situation,quantities of bulk drugs,self,centers,concerned bulk drugs,normal trade channels,discernible from the org data,board,specific particulars,prologue,established criteriaguideline,level,original record,reconsideration by the high court,value of entire production,law,emphasis,the question,take appropriate measure,act of the delegate,callousness on the part,sole,piece of medicines,org data cover,verifiable principle,flexibility,sufficient market competition viz,market sale,prima,yield different results,various levels,supra in the light,amounts,plenary legislation,price of such medicines rise,retail trade sale data,applicability,taxes,impermissible,point,vires,file of the high court,at least  formulator,comparatively lower turnover,such rules,tax,marg,september,authorities,considering the question,presumption,only a bald denial,avowed purpose,unfounded,outside price control in case,salts,domestic sales figure,appropriate,fiscal enactment,use of transparent criteria,moreover,outside price control by the application,policy document,last decade,reasons,three claus,drug qualify,actual figure,index,transparent  objective and verifiable principle,organization,good reasons,bulk drug sales,highest market share of single formulator,in the manufacture of formulations,form of formulations,agreement,requirement of objectivity justifiable,capsule,doubt in this regard,error,far the exclusion,subject the petitioners,judgment of the bombay high court,drug in the first schedule,prevalent,respect of any bulk drug,institutional sales to the extent,exhaustive account,bulk drug manufacturers,overcharged amount,one or more norms,chemical,extf,callousnes on the part,ambiguity,decision,vaguenes,reasonable view point,bench,exhaustive,niche,other word,verification of details,authority,indicated the aspects,drug sales,imported bulk drug and its production,limit,one or more other bulk drug,solicitor-general at the time of argument,close watch on the prices,policy issue,such as hospital,criteriaguidelines,sales,drug manufacturers,five known manufacturers,behalf,least ten formulators,p venkatarama reddi,reach of writ petitioners,essential commodity,more than five bulk drug producer,crucial aspect,aids,which plenary legislation,condition of a minimum,narrow,set norm,necessary,bulk drug producers,org data covers,favour,said two drug,closing the discussion,pertinent,more other bulk drug,burden ly,original writ petition record,rebuttal,post,axiomatic that the contents of a policy documents,same para of the counter,commendable,publication,issue,explanation,tabular statement,objective,turnover of any drug,spurt,backdrop of the drug policy,such matter,wide,drug procedure,justified on account of predominance,comprehensive datum,leave,consumption of bulk drug,ground on which subordinate legislation,production and import statistics,legislative action,very facts,lack,said drug,bdma,account in the interest,price control criterion,certain,statistics,considerations,share,drug qualifies for exclusion,successful,method of calculation,concerning the criterion,counsel,petitions,corollary,from org data,of retail pharma market,was no single formulator,contentions,intrinsic worth,liberty to the appellant,combination product of cloxacillin,picture of the turnover,legislative,research,expression  turnover,policy guidelines,reply,scope for subjective approach,such distinction,presumption that the entire stock,obvious error,opening clause of sub - para,watch on the prices,cases,stocks,reference to the org data,method,span,few bulk drugs,that the contents of a policy documents,when the actual figure,decide which view,more market share in retail trade,international market,than the stipulated level,true import,regarding the number,facie acceptance,is an index,cifran,assertion of the writ petitioner,carve a special niche,more aspect,first criteria,different method of calculation,difference,having regard,drug doxycycline in a concentration,prima facie acceptance,-an,mathematical,framing the first schedule,than  market share,understanding the scope,one thing,concerned drugs,legislature,laboratories,consumption,drugs  cosmetics act,independent body,use of any pharmaceutical aids,drug sale,clamp price control,vide collins,import of the bulk drug,grey,contention that the org data,effective,formulation sales,exceeding the maximum sale price,policy decision,manufacturers,powers,be the basi,finding of the high court,communication,axiomatic,minimum annual turnover of the drug,exhaustive account of turn,bulk drugs in the first schedule,annual turnover,of legalism,core,drugs policy in relation,a situation,contrary,is a different matter,march,representation of bulk drug manufacturers,dpco in a different context,that account,domestic sales figures,part of the quantities,was discrimination,legislative act of the delegate,having due regard,interpretation,legislative act,irrational,whole issue of exclusion  inclusion,factual foundation in support,however no consideration,bulk drug in the country,close,drugs  price control  order,very inclusion of these bulk drugs,condition,challenged the legislation,ultimate analysi,having an annual turnover,last,standard,same degree,year by bulk drug producers,annual domestic turnover,scientific,freedom,only one formulation,gross,factual,drug manufacturers  association,objectivity justifiable,computing turnover,not the contentious issue,assistance from the definition,year to the tune,newspaper,ambit of price control criteria,schedule,took the stand,vast difference,that the content of a policy documents,combines the dual role,apply the criterion,pharmaceutical sector,check by the forces,light of all relevant factors,be the basis,bulk drug manufacturer,twin conditions,bulk drug doxycycline,first criterion,said authority,market competition viz,week from the date,amikacin sulphate,stay of recovery,counter affidavits,different context,which view,drug  glipizide,purpose of price control,delegate of legislative power,factor,one argument,contention of the appellant,quarrel about the criteria,learned solicitor,appropriate measure,sales figures,more than five bulk drug producers,various,aspects that the government,regards,fact,vacate the findings,reach the consumer,matters,fixation,assumption,consumers through normal trade channel,movement,application because the turnover,total import,contentions of the respondents,first,animal,division,mechanics of price fixation,available in terms of the policy,unequivocal,price of essential drugs,listing,specified drugs for price control,twin condition,clauses,such formulation,import statistics,single,remedy,indias view,concerned statutory authorities,sale of bulk drug,single ingredient formulation,has multi-ingredient,manufacturer of the bulk drug,crucial,manufacturer,exclusion criterion,hereinafter,sales formulations,such criteria,drugs under price control,due,data in regard,price of these medicines rise,behalf of the respondents,org survey of march,is another shade,credibility,deposit the overcharged amount,sales to the extent,contentious,store,cosmetics,para of the counter,institutional,updating of the data,commodities act,appeal,judgment,monopoly,deciding the validity,minimum,as many as  bulk drug procedures,manufacture,be the manufacturers,economic consideration,contention,time in the rejoinder affidavit,stereo,further contention,relevant datum,than  lac,stated therein,inter,ranbaxy limited,calculate the consumption,these reason,only one formulator,export performance,question in favour,of the retail market sales,performance,j,three relevant criterion,version,term of production,definition of  turnover,direct sale,legal position,meaning of the clauses,ground that the factual particular,of the total market,experimental measure,factual foundation,such a situation,include exports,independent body of experts,earnest,such sale,special leave,two view,prescribed norms in drug policy,petrochemical,doxycycline,sales formulation,negligible,writ petitioner,proper,annexure-a,span of control,demonstrable,entirety,only three bulk drug manufacturers,requirement,interest,all these reason,export sales,purported,ingredient formulation,stereo-isomer,review,combination formulations,critical scrutiny,export sale figures,expert body,records,own guideline,same time,context,different methods,iii,alleged,discretion for relevant reasons,market share of single formulator,f,open to the government,cost,clarified the position,light,paper books,leaving the scope,writ petitioner in relation,division bench of high court,unreasonable and ultra vire,plant product,drugs,benefit of exclusion,drug from dpco,correct,repealed the earlier dpco,total imports into the country,different results,time to time,clear picture,pursuant to the provisions,mean sales,policy formulation,subordinate,ceiling levels,had the market share,body,need,national,constitution,effective rebuttal,accepted the case,stand,writ petition in the high court,discernible,exclusion of export sales,regarding the applicability,specific criteria,bulk drugs within price control,guide - posts,sale price,acceptance by the high court,estimating the sale,promote the policy,total production,event,parity,modalities,reclaim,specific particular,page,objectives,full,reliance,broadest meaning,respondents that the bulk drug,turn,deliberations,breach of policy decision,affidavit,quantity,or external use,second schedule,ceiling levels beyond which increase,meet the requirement,figure for the year,intent,drug qualify for exclusion,measures,es,element,become the guide-posts,core controversy,policy formulations,salt,under paragraph,dispute that the annual turnover,including reclaim,was every endeavour,had the turnover,consideration as regards,negligible ie,one more aspect,afford the basis,clarification,direct stay,untenable,rational use of drugs,limits,face,clear,relevant,fresh determination,and ultra vires,respondents herein,view that the crucial issues,imports of the bulk drug,includes formulations,assessment of the factors,essential,test the correctnes,certain drugs,turnover figures,regard,busines,commodity,dependable,at least  formulators,dpco empowers,accordance,hesitation,light of the clarification,clarificatory letter,bringing the drug,criteria in the drug policy,verifiable manner,increasing supplies,equitable,mean,other drugs,statute,scenario,human being,subject to the criteria,sub,cyproflaxacin,weeks from the date,tabular,that bulk drug,market share,dispute,other aspects,other words,drugs with the minimum use,different points,term,was rs,avowed purpose of price control,area,furnish any details,record,glipizide,classification,estimated consumption,estimating the sales,available at the doorsteps of the respondents,conditions of a minimum,vacate the finding,rejecting the representation,exclusion of other drugs,furnish any detail,sales tax and other fiscal enactments--reliance,only single ingredient formulation,resolve,misapprehension that the writ petitioner,regarding sale,drug turnover,is the further case,commerce,was any other producer,enactments,detail of production,extf to the writ petition,indigenous production,alse-general at the time of argument,brand name of doxy-,prices of these drugs,estimate of turnover,common judgment of the bombay high court,stressed the need,material facts,further liberalization,representation of bulk drugs manufacturers association,found favour,drug policy document,should the export sale,captivity,relevant in the sense,ultra,do the work,judgment of the high court,ordinary meaning,beings,payment,controvert the contention,production,scientific or rational assessment,multi-ingredient,essential drugs,pharmaceutical aids,datum,petition,appeals,supra,way for further liberalization,sub-paragraph,determinative,estimates of turnover,manufacturer of formulations,figures by an expert group,legalism,ground that the factual particulars,infraction of article,hay,direct,mechanism,usv limited,appellants,response,of turnover,fair price,retail trade sale datum,be the datum,degree of immunity,nobody,real and earnest attempt,dependable exporter,retail market,or more market share,control--,external,availability,much against the spirit of the policy,calculate market share,respectful,local taxes,three clauses,data,les,face value,prescribed,backdrop,relevant factor,single ingredient,only single ingredient formulations,different matter,ground on which plenary legislation,claim,sale data,stand point of article,liberalization,violative of article,writ petitioners  claims,reconsideration of price fixation,formulation sale,instance,various angle,expression  formulators,date,imports furnish,estimated the turnover figure,regulating the price,lower,application,org data relate,reason,apparent misapprehension that the writ petitioner,calculating the turnover,sale values,unequivocal term,controversies,national pharmaceutical pricing authority,economic,why export sales,sum,satisfies,one more point,adopting such approach,there sufficient market competition,words,landed cost,written submission,various factors,learned solicitor - general,four weeks,make such rules,writ petitions in the high court,drug industry,case of the petitioner,particular bulk drug,reach the consumers,eight drug,pieces,only seven known formulators,purposive,notified price,- diabetic drug,different result,statutory provisions,ranbaxy laboratories ltd,ambit,value of domestic production,doorsteps,observations,ltd,datum in regard,basis of a bald plea,relation,meaning,subordinate legislation,mechanic of price fixation,view that single ingredient formulator,benefit,take appropriate measures,january,trends,producer of bulk drug,surrounding the criterion,export potential,known manufacturer,other fiscal enactments,analysi,violation,crucial aspects,contents,said paragraph,that expression,foreign,very fact,prohibition against the sale,good,production and import statistic,make such rule,wrath of article,view that the reason,apprehension,express newspaper,association,legal,consideration of sale values,guide - post,slp,hospital,relevant criterion in the drug policy,amount of business,has benefit,true,different,apparent,ingredient formulations,even lay,landed,only what,laboratories ltd,venkataramiah,total imports,an approach,how the turnover,direct sale to institutions,different point,subordinate law - making authority,application because no single manufacturer,sit,minimum use,original,twin condition of a minimum,having adequate competition,issue of exclusion  inclusion,shade,central government as the delegate,notify the specified drugs,basis of clause,production in the country,reversing the conclusion,whole,indian express newspaper,four week,meet the requirements,established criteria,frank disclosure,quantum of consumption,lakh,drugs under the price control,expression,various formulation,principle,demonstrable justification,understand that expression,maker,turnover need,writ petitioners in relation,guard,minimize the scope,favour with the high court,narrow connotation of the word,prices,more than the stipulated level,factual aspect,interest of consumers,correctness of this contention,averments,conditions,survey,have regard,way of formulations,doubt,representation on dt,particular formulator,most of the arguments,is vast difference,alse general,diabetic,acid,means,sub-para,mechanic,limit of rs,prescribed norms,internal,single drug ingredient formulation,challenge the legislation,market share of a formulator,market price,importer,division bench,correctnes of this contention,revenue,material fact,other bulk drug,stand of union,for exclusion in the light,callousness,single ingredient formulators,ordinary or legal sense,case of the petitioners,submissions,seek reconsideration,monitor the trends,specified period,exclusion in the light,business,so called principle,precludes the high court,learned solicitor general in the course,various levels throughout the deliberation,reasoned order,services,drugs into account,twin,turnover of the bulk drug doxycycline,spirit of the policy,rejoinder,quantum,petitioner - company,surrounding the criteria,make any difference,list,sale value,foreign country,demanding overcharged amounts,was no monopoly situation,relevant for the purpose,petitioner in writ petition,maximum sale price,intricacies,reliable and comprehensive datum,based formulation,withheld the relevant data,should the export sales,through the retail store audit,mean a medicine,levels,transparent,use in the diagnosis,sub-paras,erroneous assumption that insulin,on the ground,at a fair price,grounds of slp,validity of legislation,one formulator,bald denial,understanding the expression,basis,parliament on the likely spurt,strict,breach,retail sale data pertains,sale data pertains to formulations,most important paragraph,inasmuch,specific criterion,bulk drug stands,called principle of parity,annual turnover of rs,afford the basi,possible,charter,in term,include the drug,ultimate analysis,yardstick,paras,submission,hearing of the writ petitions,turnover for the year,few bulk drug,argument that insulin,check,international,procedures,modalities of fixation,concentration,wastage,guesswork,for policy issues,one or two drug,giving distorted meaning,drug in the country,appellant or,discernible from org data,turnover of this drug,estimated basis,important bulk drugs within price control,primary,ingredient of the bulk drug,argument,either deviation from the criteria,imports furnishes,turnover to the value,such approach,vast variation between the quantity,trade channels,drug of popular use,determination by the high court,where the central government,policy,rsa,different criteria,implementation of the policy,actual sale,case of the drug cyproflaxacin,pricing,represents the sale value,reclaim of price control,attract the wrath,bulk,none of these aspects,ordinary,erroneous,known manufacturers of bulk drug,towards hospital,ceiling level,venkatarama,starting,exclusioninclusion,was either deviation,quantities,exclusion of the drug cloxacillin,different criterion,high turnover of a drug,give exhaustive account,bye,sales of bulk drugs,unjustified,flout,be frank disclosure,sum total,lays,regarding the quantum,communication of the amount,official of the department,implementation,furnish some basis,posts,petitioners,annexure-a to the writ petition at pages,which subordinate legislation,invalidate delegated legislation,paragraph,details of production,be demonstrable justification,combination,isomers,figure--,work of price fixation,dcpo,common,were the sole manufacturers,criterion in clause,estimating the turnover,doxy-,require reconsideration,methods,same by the mrp,such rule,criterion in the drug policy,mischief,compilation,article,established criteriaguidelines,critical,mechanics,fiscal enactments,flexibility in approach,at least five producers,number of formulators,book,challenge,worth,of compliance,scheduled drugs,concerned,date for turnover,leave an imprint,debilitate the set norm,violation of article,export sale,single ingredient formulator,claim of the petitioner - company,said bulk drugs,carry the same degree,producers,course,strict watch,or legal sense,pattern,exclusion under clause,depend,violence,error in the high court,guideline,determine the ceiling level,purview of dcpo,infraction,findings of the high court,enabling legislation,price,drug procedures,categorization for the purpose,high court s view,such medicines,turnover of a drug,view point,contentious issue,is a monopoly situation,delegated legislation,objective and verifiable principle,only three bulk drug manufacturer,number of drugs,comprehensive datum of sales,extended the benefit,halfhearted attempt,pre-fixed guidelines,imports into the country,computing the annual turnover need,imports,intended authority,affidavit - in - reply,arbitrary,drug during the relevant period,withheld the relevant datum,eight drugs,two drug,results,connotes amount,specified drugs,drug doxycycline,plea of writ petitioners,rational policy,all the drugs,nppa,conclusive,bald denial in the counter affidavit,follows the policy formulation,ltd inter alia,vide annexure,reasoning,has obvious reference,test the correctness,sulphate,crucial issue,preamble,acceptance,from the affidavits on record,latitude,view that the reasons,meeting the point,being the case,likely,annual turnover need,difficult,viewing the price scenario,clarificatory,rate,dpco empower,excluding the hospital,advance the case,contention that the org datum,more market share in the retail trade,or rational assessment,freedom of classification,rejoinder affidavit,relevant reason,insulin,requirements,high,been the reason,disregarding the very facts,calculation,retail sale data of the formulations,details,c,specified drug for price control,sale of bulk drugs,guide,account for the purpose,even lays,bulk drug turnover,ultra vires,to the institution,sense,quantum of turnover,is no need,other aspect,effect,multi-ingredients,counter affidavit that the retail trade sale data,actual figures,argument of the learned counsel,yardstick rhea,terms of the policy,lay,important paragraph in the drug policy ie,sales within the country,that the high turnover of a drug,including the petitioner,consumption of the bulk drug,sales figure,ii,policy guideline,weighted average,org-marg,purpose of criterion,imported bulk drug,policy issues,other standards,suitable,real,relation to those drugs,indicia,certain factual aspects,subject,has no application,giving due allowance,halfhearted,total market,are the question,go - bye,drug producers,prevailing market price,intricacies of price fixation,not a ground,formulation of a bulk drug,drug manufacturer,commodities,quarrel,angle,specified bulk drug,contention of the respondents,exercising such discretion,updating,maximum,government organization,pharma market in india contributes,determine the ceiling levels,anti - diabetic drug,trade,at least  bulk drug manufacturers,total busines,channels,indigenous production in the country,measure,mg per capsule,hay-wire,contextual,assistance,reasonable limits,respondent - companies,trade channel,external use,books,highest market share of single drug ingredient formulation,relevant criteria,trade sale data,counter affidavit of union,concept of  turnover,containing the particular bulk drug,laboratory,essential drug,central government in exercise,that formulation,annual turnover requirement,such criterion,vide,schedule to the drugs,equitable distribution,clear that the production,v union,at least ten formulators,rational basis,attention,as many as  formulations,indicia of domestic sale turnover,construction of statutes,conclusions,important bulk drugs,org figure for the year,inquiry,stands,actual data,more market share,at least ten formulator,figure,meticulou,way,writ petitioners  claim,slps,indian express newspapers v union,drug on the basis,particulars of sales,immediate,collins,saw no need,indicated the aspect,v,variation,others,judges,need for reconsideration,overcharged,opposed,view that the crucial issue,common judgment,above drugs,associate research director,appeal by special leave,be the minimum annual turnover,important paragraph,lacs,behalf of the union,market,audit,sale value of bulk drug,satisfied,emphasi,than five bulk drug producer,production data,purview of the dpco,clear picture of the turnover,set,enactment,justification,other reliable and comprehensive data,org figures,brand,writ petitioner - company,org figure,and clear picture,ester,factors,conclusion,includes export sale,bulk drug manufacturers  association,probe,transparent criteria,broadest,writ petitioner s contention,yield different result,content of a policy documents,annual turnover of the drug,ten formulators,india contribute,vide collin,as hospitals,stay,statement,respect,satisfy,concept,production datum,seven bulk drugs,unequivocal terms,therefrom,become the guide-post,normal,respondent - company,goes a step,bring these important bulk drugs,first schedule on the basis,test of article,actual application,means of imports,certain bulk drug,very inclusion,seven formulators,contention of the writ petitioners,force,bald denial in the affidavit,stand of the central government,amount of money,statutory authority,company,adopt transparent criterion,multi-ingredient formulators,fit,drug producer,notified price prevalent,outside price control,special,amount subject,record of high court,clause,distorted meaning,value of total production,extent of usage,assessing the turnover,specified,industry,relevant factors,sales value